Hirosaki Yuri, Hayashidani Shunji, Ouchi Sayako, Ohshima Tukasa, Nakano Ryuji, Yamamoto Hideo
Department of Internal Medicine, Japan Community Health Care Organization (JCHO) Kyushu Hospital, 1-8-1 Kishinoura Yahata-Nishiku, Kitakyushu City, Fukuoka Prefecture, 806-8501, Japan.
Department of Pathology, Japan Community Health Care Organization (JCHO) Kyushu Hospital, 1-8-1 Kishinoura Yahata-Nishiku, Kitakyushu City, Fukuoka Prefecture, 806-8501, Japan.
J Med Case Rep. 2015 Apr 28;9:90. doi: 10.1186/s13256-015-0544-5.
Idiopathic systemic capillary leak syndrome is a rare and fatal disease due to the unexplained episodic attacks of capillary leakage of plasma from the intravascular into the interstitial space. The attack consists of three phases, a prodromal phase, peripheral leak phase and recruitment phase. During the peripheral leak phase, generalized edema, mainly in the trunk and extremities, with hemoconcentration and hypoalbuminemia occurs, while usually the visceral organs like lungs, brain, heart and kidneys seem not to be involved. Treatment of the acute phase is supportive, focusing on adequate but not overzealous fluid resuscitation, because pulmonary edema usually occurs in the recruitment phase.
A 65-year-old Japanese woman was admitted to our hospital because of severe hypovolemic shock with metabolic acidosis and hemoconcentration and hypoalbuminemia. Although she was considered to be in the peripheral leak phase of idiopathic systemic capillary leak syndrome, which could not be diagnosed during the treatment, the generalized edema worsened further, severe flash pulmonary edema progressed rapidly after fluid resuscitation and she died. The autopsy showed generalized edema, especially alveolar pulmonary edema without endothelial apoptosis.
Because hypovolemic shock and fatal pulmonary edema may progress rapidly together even in the peripheral leak phase of idiopathic systemic capillary leak syndrome, we should keep in mind this rare and fatal disease and recognize the pathophysiology to treat it effectively when the patient has hypovolemia with metabolic acidosis.
特发性系统性毛细血管渗漏综合征是一种罕见的致命疾病,其特征为不明原因的血浆从血管内间歇性渗漏至间质间隙。发作分为三个阶段,前驱期、外周渗漏期和恢复期。在外周渗漏期,主要在躯干和四肢出现全身性水肿,并伴有血液浓缩和低白蛋白血症,而肺、脑、心脏和肾脏等内脏器官通常似乎未受累。急性期的治疗以支持治疗为主,重点是进行适当但不过度的液体复苏,因为肺水肿通常发生在恢复期。
一名65岁的日本女性因严重低血容量性休克伴代谢性酸中毒、血液浓缩和低白蛋白血症入住我院。尽管她被认为处于特发性系统性毛细血管渗漏综合征的外周渗漏期,但在治疗期间无法确诊,全身性水肿进一步加重,液体复苏后严重的急性肺水肿迅速进展,最终死亡。尸检显示全身性水肿,尤其是肺泡性肺水肿,无内皮细胞凋亡。
即使在特发性系统性毛细血管渗漏综合征的外周渗漏期,低血容量性休克和致命性肺水肿也可能迅速共同进展,因此当患者出现低血容量伴代谢性酸中毒时,我们应牢记这种罕见的致命疾病,并认识其病理生理学以便有效治疗。